Press Releases from DelveInsight Business Research LLP (4751 total)
Keratoconus Therapeutics Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Keratoconus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Keratoconus, historical and forecasted epidemiology as well as the Keratoconus…
Graves Ophthalmopathy Therapeutics Market Size in 7MM is expected to grow at a d …
DelveInsight's " Graves Ophthalmopathy Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Graves Ophthalmopathy, historical and forecasted epidemiology as well…
Wet Age-Related Macular Degeneration Therapeutics Market Size in 7MM is expected …
DelveInsight's "Wet Age-Related Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Wet Age-Related Macular Degeneration, historical and forecasted…
Hay Fever Conjunctivitis Therapeutics Market Size in 7MM is expected to grow at …
DelveInsight's "Hay Fever Conjunctivitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hay Fever Conjunctivitis, historical and forecasted epidemiology as…
Dry AMD Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by …
DelveInsight's "Dry AMD Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Dry AMD, historical and forecasted epidemiology as well as…
Psoriasis Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsight …
Psoriasis Pipeline constitutes 80+ key companies continuously working towards developing 80+ Psoriasis treatment therapies, analyzes DelveInsight.
Psoriasis Overview:
Psoriasis is a long-term inflammatory skin condition that presents…
Obesity Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsight | …
Obesity Pipeline constitutes 80+ key companies continuously working towards developing 100+ Obesity treatment therapies, analyzes DelveInsight.
Obesity Overview:
**Obesity** refers to the **abnormal or excessive buildup of…
Ocular Hypertension Pipeline Analysis and Clinical Trials Assessment, 2025 by De …
Ocular Hypertension Pipeline constitutes 50+ key companies continuously working towards developing 75+ Ocular Hypertension treatment therapies, analyzes DelveInsight.
Ocular Hypertension Overview:
Ocular hypertension refers to increased pressure…
Osteoarthritis Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveIn …
Osteoarthritis Pipeline constitutes 100+ key companies continuously working towards developing 110+ Osteoarthritis treatment therapies, analyzes DelveInsight.
Osteoarthritis Overview:
Osteoarthritis (OA) is the most prevalent type of arthritis,…
Pancreatic Ductal Adenocarcinoma Pipeline Analysis and Clinical Trials Assessmen …
Pancreatic Ductal Adenocarcinoma Pipeline constitutes 80+ key companies continuously working towards developing 80+ Pancreatic Ductal Adenocarcinoma treatment therapies, analyzes DelveInsight.
Pancreatic Ductal Adenocarcinoma Overview:
Pancreatic ductal adenocarcinoma…
Prostate Cancer Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveI …
Prostate Cancer Pipeline constitutes 140+ key companies continuously working towards developing 150+ Prostate Cancer treatment therapies, analyzes DelveInsight.
Prostate Cancer Overview:
Prostate cancer develops when cells in…
Pancreatic Neuroendocrine Tumors Therapeutics Market Size in 7MM is expected to …
DelveInsight's "Pancreatic Neuroendocrine Tumors Drugs Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Pancreatic Neuroendocrine Tumors, historical and forecasted…
PD-L1 Inhibitors Therapeutics Market Size in 7MM is expected to grow at a decent …
DelveInsight's "PD-L1 Inhibitors Market Insight, Epidemiology and Market Forecast - 2034" report delivers an in-depth analysis of PD-L1 inhibitors epidemiology, market, and clinical development understanding…
PD-L1 Metastatic Non-small Cell Lung Cancer Therapeutics Market Size in 7MM is e …
DelveInsight's "PD-L1 Metastatic Non-small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the PD-L1 Metastatic Non-small Cell Lung…
PEComa Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2 …
DelveInsight's "PEComa Market Insights, Epidemiology, and Market Forecast-2034" Report delivers an in-depth understanding of the PEComa, historical and forecasted epidemiology as well as the PEComa…
Pediatric Brain Tumors Therapeutics Market Size in 7MM is expected to grow at a …
DelveInsight's "Pediatric Brain Tumors Market Insights, Epidemiology, and Market Forecast-2034" Report delivers an in-depth understanding of the Pediatric Brain Tumors, historical and forecasted epidemiology as…
Non-Small-Cell Lung cancer (NSCLC) Pipeline Analysis and Clinical Trials Assessm …
Non-Small-Cell Lung cancer (NSCLC) Pipeline constitutes 100+ key companies continuously working towards developing 120+ Non-Small-Cell Lung cancer (NSCLC) treatment therapies, analyzes DelveInsight.
Non-Small-Cell Lung cancer (NSCLC)…
Non-Alcoholic Fatty Liver Disease Pipeline Analysis and Clinical Trials Assessme …
Non-Alcoholic Fatty Liver Disease Pipeline constitutes 90+ key companies continuously working towards developing 100+ Non-Alcoholic Fatty Liver Disease treatment therapies, analyzes DelveInsight.
Non-Alcoholic Fatty Liver Disease…
Neuroendocrine tumors Pipeline Analysis and Clinical Trials Assessment, 2025 by …
Neuroendocrine tumors Pipeline constitutes 100+ key companies continuously working towards developing 120+ Neuroendocrine tumors treatment therapies, analyzes DelveInsight.
Neuroendocrine tumors Overview:
Neuroendocrine cancer, also known as a…
Advanced Cancer Pain Management Therapeutics Market Size in 7MM is expected to g …
DelveInsight's "Advanced Cancer Pain Management Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Advanced Cancer Pain Management, historical and forecasted…
Gastroesophageal Junction Adenocarcinoma Therapeutics Market Size in 7MM is expe …
elveInsight's "Gastroesophageal Junction Adenocarcinoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Gastroesophageal Junction Adenocarcinoma, historical and forecasted…
Meningioma Therapeutics Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Meningioma Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the Meningioma, historical and forecasted epidemiology as well as the Meningioma…
HPV16+ Anogenital Cancers Therapeutics Market Size in 7MM is expected to grow at …
DelveInsight's "HPV16+ Anogenital Cancers Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the HPV16+ Anogenital Cancers, historical and forecasted epidemiology as…
Triple Refractory Multiple Myeloma Therapeutics Market Size in 7MM is expected t …
DelveInsight's "Triple Refractory Multiple Myeloma Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the Triple Refractory Multiple Myeloma, historical and forecasted…
Pediatric Brain Tumors Therapeutics Market Size in 7MM is expected to grow at a …
DelveInsight's "Pediatric Brain Tumors Market Insights, Epidemiology, and Market Forecast-2034" Report delivers an in-depth understanding of the Pediatric Brain Tumors, historical and forecasted epidemiology as…
Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Therapeutics Market Size in 7M …
DelveInsight's "Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Mucosa-associated Lymphoid Tissue (MALT) Lymphoma, historical…
Bowen's Disease Therapeutics Market Size in 7MM is expected to grow at a decent …
DelveInsight's "Bowen's Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Bowen's Disease, historical and forecasted epidemiology as well as…
Parkinson's Disease Pipeline Analysis and Clinical Trials Assessment, 2025 by De …
Parkinson's Disease Pipeline constitutes 130+ key companies continuously working towards developing 150+ Parkinson's Disease treatment therapies, analyzes DelveInsight.
Parkinson's Disease Overview:
Parkinson's disease (PD) is a long-term,…
Ocular Hypertension Pipeline Analysis and Clinical Trials Assessment, 2025 by De …
Ocular Hypertension Pipeline constitutes 50+ key companies continuously working towards developing 75+ Ocular Hypertension treatment therapies, analyzes DelveInsight.
Ocular Hypertension Overview:
Ocular hypertension refers to a condition…
Chronic Lymphocytic Leukemia Pipeline Analysis and Clinical Trials Assessment, 2 …
Chronic Lymphocytic Leukemia Pipeline constitutes 55+ key companies continuously working towards developing 60+ Chronic Lymphocytic Leukemia treatment therapies, analyzes DelveInsight.
Chronic Lymphocytic Leukemia Overview:
Chronic lymphocytic leukemia…
Nephrotic Syndrome Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …
Nephrotic Syndrome Pipeline constitutes 3+ key companies continuously working towards developing 3+ Nephrotic Syndrome treatment therapies, analyzes DelveInsight.
Nephrotic Syndrome Overview:
**Nephrotic Syndrome** is a collection of…
Netherton Syndrome Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …
Netherton Syndrome Pipeline constitutes 5+ key companies continuously working towards developing 5+ Netherton Syndrome treatment therapies, analyzes DelveInsight.
Netherton Syndrome Overview:
**Netherton Syndrome (NS)** is a rare…
Opioid Withdrawal Syndrome Pipeline Analysis and Clinical Trials Assessment, 202 …
Opioid Withdrawal Syndrome Pipeline constitutes 4+ key companies continuously working towards developing 4+ Opioid Withdrawal Syndrome treatment therapies, analyzes DelveInsight.
Opioid Withdrawal Syndrome Overview:
Opioid Withdrawal Syndrome…
Parainfluenza Virus Infection Pipeline Analysis and Clinical Trials Assessment, …
Parainfluenza Virus Infection Pipeline constitutes 5+ key companies continuously working towards developing 5+ Parainfluenza Virus Infection treatment therapies, analyzes DelveInsight.
Parainfluenza Virus Infection Overview:
The human parainfluenza…
Multiple sclerosis Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …
Multiple sclerosis Pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple sclerosis treatment therapies, analyzes DelveInsight.
Multiple sclerosis Overview:
Multiple sclerosis (MS) is the most…
Myelodysplastic Syndrome Pipeline Analysis and Clinical Trials Assessment, 2025 …
Myelodysplastic Syndrome Pipeline constitutes 120+ key companies continuously working towards developing 125+ Myelodysplastic Syndrome treatment therapies, analyzes DelveInsight.
Myelodysplastic Syndrome Overview:
Myelodysplastic syndrome (MDS) is a diverse…
Natural Killer Cell Therapies Pipeline Analysis and Clinical Trials Assessment, …
Natural Killer Cell Therapies Pipeline constitutes 100+ key companies continuously working towards developing 140+ Natural Killer Cell Therapies treatment therapies, analyzes DelveInsight.
Natural Killer Cell Therapies…
Obstructive Sleep Apnea Pipeline Analysis and Clinical Trials Assessment, 2025 b …
Obstructive Sleep Apnea Pipeline constitutes 20+ key companies continuously working towards developing 21+ Obstructive Sleep Apnea treatment therapies, analyzes DelveInsight.
Obstructive Sleep Apnea Overview:
Obstructive Sleep Apnea…
Nontuberculous Mycobacterial Infections Pipeline Analysis and Clinical Trials As …
Nontuberculous Mycobacterial Infections Pipeline constitutes 10+ key companies continuously working towards developing 10+ Nontuberculous Mycobacterial Infections treatment therapies, analyzes DelveInsight.
Nontuberculous Mycobacterial Infections Overview:
Nontuberculous Mycobacterial (NTM)…
Myotonic Dystrophy Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …
Myotonic Dystrophy Pipeline constitutes 20+ key companies continuously working towards developing 22+ Myotonic Dystrophy treatment therapies, analyzes DelveInsight.
Myotonic Dystrophy Overview:
Myotonic Dystrophy (DM) is the most…
Food Allergy Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsi …
Food Allergy Pipeline constitutes 25+ key companies continuously working towards developing 30+ Food Allergy treatment therapies, analyzes DelveInsight.
Food Allergy Overview:
Food allergies are harmful immune responses…
Smoking Cessation and Nicotine Addiction Pipeline Analysis and Clinical Trials A …
Smoking Cessation and Nicotine Addiction Pipeline constitutes 5+ key companies continuously working towards developing 5+ Smoking Cessation and Nicotine Addiction treatment therapies, analyzes DelveInsight.
Smoking Cessation…
Sepsis Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsight | …
Sepsis Pipeline constitutes 25+ key companies continuously working towards developing 30+ Sepsis treatment therapies, analyzes DelveInsight.
Sepsis Overview:
Sepsis is a critical and potentially fatal condition that…
Focal Segmental Glomerulosclerosis Pipeline Analysis and Clinical Trials Assessm …
Focal Segmental Glomerulosclerosis Pipeline constitutes 15+ key companies continuously working towards developing 18+ Focal Segmental Glomerulosclerosis treatment therapies, analyzes DelveInsight.
Focal Segmental Glomerulosclerosis Overview:
Focal Segmental Glomerulosclerosis…
Janus Kinase (JAK) Inhibitor Pipeline Analysis and Clinical Trials Assessment, 2 …
Janus Kinase (JAK) Inhibitor Pipeline constitutes 50+ key companies continuously working towards developing 55+ Janus Kinase (JAK) Inhibitor treatment therapies, analyzes DelveInsight.
Janus Kinase (JAK) Inhibitor…
Gastrointestinal Stromal Tumors (GIST) Pipeline Analysis and Clinical Trials Ass …
Gastrointestinal Stromal Tumors (GIST) Pipeline constitutes 25+ key companies continuously working towards developing 28+ Gastrointestinal Stromal Tumors (GIST) treatment therapies, analyzes DelveInsight.
Gastrointestinal Stromal Tumors (GIST)…
Glioblastoma Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsi …
Glioblastoma Pipeline constitutes 180+ key companies continuously working towards developing 200+ Glioblastoma treatment therapies, analyzes DelveInsight.
Glioblastoma Overview:
Glioblastoma Multiforme (GBM) is the most common and aggressive…
Systemic Lupus Erythematosus Clinical and Non-Clinical Studies, Key Companies, T …
Systemic Lupus Erythematosus Pipeline constitutes 120+ key companies continuously working towards developing 140+ Systemic Lupus Erythematosus treatment therapies, analyzes DelveInsight.
Systemic Lupus Erythematosus Overview:
Systemic Lupus Erythematosus…
Wet Age-Related Macular Degeneration (Wet-AMD) Clinical and Non-Clinical Studies …
Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline constitutes 60+ key companies continuously working towards developing 70+ Wet Age-Related Macular Degeneration (Wet-AMD) treatment therapies, analyzes DelveInsight.
Wet Age-Related…
Liver Cirrhosis Clinical and Non-Clinical Studies, Key Companies, Therapeutic As …
Liver Cirrhosis Pipeline constitutes 30+ key companies continuously working towards developing 30+ Liver Cirrhosis treatment therapies, analyzes DelveInsight.
Liver Cirrhosis Overview:
Liver cirrhosis is a chronic condition…
